Olfactory Disorder
31
5
5
15
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (31)
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
Sinus Disease in Young Children With Cystic Fibrosis
Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
Olfactory Training in Various Populations
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
Radiofrequency Intervention in Neurological Pathologies Post COVID-19
Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction
Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD
Oral and Olfactory Complications of Recovered COVID-19 Patients
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
Olfactory Performance in Culinary Arts Students
At-Home Olfactory Training
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
Smell in Covid-19 and Efficacy of Nasal Theophylline
Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction